Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 88
Filter
1.
J Clin Microbiol ; 32(3): 783-9, 1994 Mar.
Article in English | MEDLINE | ID: mdl-8195394

ABSTRACT

A shared-primer PCR method for the detection of infection was developed by using primers derived from DNA sequences upstream of the structural genes for the porin proteins of Bordetella pertussis and Bordetella parapertussis. This method resulted in a 159-bp PCR product specific for B. pertussis and a 121-bp DNA fragment specific for B. parapertussis and allowed for the simultaneous detection of these pathogens. The PCR procedure was shown to be very specific since no PCR product was obtained from 36 non-Bordetella bacterial DNAs. Nasopharyngeal aspirates (NPAs) from children suspected of having pertussis were evaluated by the PCR method, culture, and the Chinese hamster ovary (CHO) cell assay, which detects pertussis toxin. B. pertussis was cultured from 119 of 205 NPAs assayed, and the presence of pertussis toxin was detected in 69 of the NPAs by the CHO cell assay. When ethidium bromide staining was used to detect PCR products, 100 NPAs gave positive results by shared-primer PCR; 94 of these NPAs were also positive by culture. The result indicated a sensitivity of 79% for PCR when culture was used as the standard. The sensitivity of PCR was increased to 95% when a digoxigenin immunoblot system was used. An additional 20 NPAs from patients with suspected pertussis that were culture negative also gave positive results by PCR. The specific and sensitive PCR method described here should be useful for both the clinical diagnosis of pertussis and case identification in vaccine trials.


Subject(s)
Bordetella pertussis/genetics , Polymerase Chain Reaction/methods , Whooping Cough/diagnosis , Animals , Base Sequence , Biological Assay , Bordetella/genetics , Bordetella pertussis/isolation & purification , CHO Cells , Child , Cricetinae , DNA Primers/genetics , DNA, Bacterial/genetics , Evaluation Studies as Topic , Genes, Bacterial , Humans , Molecular Sequence Data , Nasopharynx/microbiology , Polymerase Chain Reaction/statistics & numerical data , Porins/genetics , Sensitivity and Specificity , Species Specificity
3.
Mol Microbiol ; 5(7): 1649-56, 1991 Jul.
Article in English | MEDLINE | ID: mdl-1658537

ABSTRACT

Bordetella pertussis produces a porin protein which is a prominent outer membrane component found in both virulent and avirulent strains. N-terminal amino acid analysis of purified B. pertussis porin was performed and this amino acid sequence was used to design an oligonucleotide that was then utilized to screen a lambda gt11 library containing randomly sheared fragments of DNA from B. pertussis strain 347. One clone, lambda BpPor, was identified and subcloned into pUC18. A portion of the DNA insert in this subclone, pBpPor1, was sequenced and shown to contain the N-terminal region of the structural porin gene. This truncated gene sequence was used to design an additional oligonucleotide that was used to identify a clone, pBpPor2, which overlapped with pBpPor1 and contained a termination codon. The structural gene deduced from this sequence would encode a 365-amino-acid polypeptide with a predicted mass of 39,103 daltons. The predicted product also contains a signal sequence of 20 residues that is similar to that found in other porin genes. The predicted B. pertussis porin protein sequence contains regions that are homologous to regions found in porins expressed by Neisseria species and Escherichia coli, including the presence of phenylalanine as the carboxy-terminal amino acid. DNA hybridization studies indicated that both virulent and avirulent strains of B. pertussis contain only one copy of this gene and that Bordetella bronchiseptica and Bordetella parapertussis contain a similar gene.


Subject(s)
Bacterial Outer Membrane Proteins/genetics , Bordetella pertussis/genetics , Amino Acid Sequence , Bacterial Outer Membrane Proteins/chemistry , Base Sequence , Bordetella/classification , Bordetella/genetics , Cloning, Molecular , Escherichia coli/genetics , Gene Library , Genes, Bacterial , Molecular Sequence Data , Neisseria gonorrhoeae/genetics , Open Reading Frames/genetics , Porins , Sequence Alignment , Sequence Homology, Nucleic Acid
4.
J Infect Dis ; 163(1): 135-42, 1991 Jan.
Article in English | MEDLINE | ID: mdl-1984460

ABSTRACT

The human serologic response to several envelope-associated proteins and adenylate cyclase toxin of Bordetella pertussis was examined using immunoblot techniques. Antigens recognized by sera from individuals with culture-confirmed pertussis and by sera from infants immunized with three doses of conventional whole-cell pertussis vaccine included a 63,000-Da protein that was shown to be antigenically related to a mycobacterial heat-shock protein. A 29,000-Da protein reacted with sera from convalescent individuals, whereas a 91,000-Da protein reacted with sera from vaccinated individuals. Antibodies to adenylate cyclase toxin were common in sera from individuals diagnosed with pertussis. B. pertussis lipooligosaccharide was also recognized by antibodies in some of these sera. These data suggest that some of these antigens may play a role in immunity to pertussis.


Subject(s)
Adenylate Cyclase Toxin , Antibodies, Bacterial/biosynthesis , Bacterial Proteins/immunology , Bordetella pertussis/immunology , Virulence Factors, Bordetella/immunology , Adult , Antigens, Bacterial/immunology , Bordetella pertussis/enzymology , Child , Diphtheria-Tetanus-Pertussis Vaccine/immunology , Humans , Immunoblotting , Infant , Middle Aged , Molecular Weight , Whooping Cough/immunology
5.
Infect Immun ; 58(12): 4045-8, 1990 Dec.
Article in English | MEDLINE | ID: mdl-2254029

ABSTRACT

The ability of heat-labile toxin (HLT) from Bordetella parapertussis to induce skin lesions in guinea pigs was found to be inhibited by lipids isolated from skin layers of adult mice, which are refractory to the lesion-inducing activity of HLT. These lipids were identified as linoleic and oleic acids. Other long-chain unsaturated fatty acids were also found to inhibit HLT; however, fatty alcohols, neutral lipids, phospholipids, cholesterol, prostaglandin, and leukotriene had no measurable effects on HLT action. The data presented in this report indicate that the ability of HLT to induce skin lesions in animals may depend, at least in part, on the free fatty acid content of the skin layer.


Subject(s)
Bacterial Toxins/antagonists & inhibitors , Bordetella/analysis , Fatty Acids/pharmacology , Transglutaminases , Virulence Factors, Bordetella , Animals , Bacterial Toxins/toxicity , Bordetella/pathogenicity , Fatty Acids/analysis , Guinea Pigs , Mice , Rats , Skin/chemistry , Skin/drug effects , Species Specificity
6.
Infect Immun ; 58(12): 4063-8, 1990 Dec.
Article in English | MEDLINE | ID: mdl-2254030

ABSTRACT

Immunization with the B oligomer of pertussis toxin protected neonatal mice from a lethal respiratory challenge with Bordetella pertussis. All mice immunized with 8 micrograms of B oligomer survived aerosol challenge and had peripheral leukocyte counts and weight gains similar to those of mice immunized with pertussis toxoid before challenge and to those of control mice that were not challenged. Unprotected mice challenged with an aerosol of B. pertussis had an increase in peripheral leukocyte count, failed to gain weight, and died within 21 days of challenge. Protection appeared to be dose dependent, since a dose of 1 microgram of B oligomer per mouse prevented death in 100% of the mice challenged with B. pertussis, whereas 0.4 micrograms of B oligomer protected 50% of the challenged mice. Mice immunized with the B oligomer had increases in immunoglobulin G (IgG) anti-B oligomer in sera and in IgG and IgA anti-B oligomer in bronchoalveolar lavage fluids 1 to 3 weeks after respiratory challenge. Specific anti-B oligomer antibodies could not be detected in unimmunized, infected mice at the same time after challenge. Intravenous administration of the monoclonal antibody 170C4, which binds to the S3 subunit of the B oligomer, protected neonatal mice from B. pertussis respiratory challenge, while administration of an IgG1 anti-tetanus toxin monoclonal antibody, 18.1.7, was not protective. We conclude that anti-B-oligomer-mediated neutralization of pertussis toxin is one mechanism of protection in the mouse model of B. pertussis aerosol challenge.


Subject(s)
Pertussis Toxin , Virulence Factors, Bordetella/immunology , Whooping Cough/prevention & control , Animals , Animals, Newborn , Antibodies, Bacterial/biosynthesis , Antibodies, Monoclonal/immunology , Immunization , Immunoglobulin G/immunology , Leukocyte Count , Mice , Mice, Inbred BALB C
7.
Biologicals ; 18(4): 309-13, 1990 Oct.
Article in English | MEDLINE | ID: mdl-2285503

ABSTRACT

A cell culture assay for heat-labile toxin isolated from Bordetella parapertussis has been developed. In this assay, the ability of heat-labile toxin to induce contraction of vascular smooth muscle cells is measured. The method allows for detection of as little as 0.6 ng/ml of the toxin. The results obtained from this in vitro assay correlated well with those obtained with in vivo assays indicating that the cell culture assay may be a useful alternative to animal assays.


Subject(s)
Bacterial Toxins/analysis , Biological Assay/methods , Transglutaminases , Virulence Factors, Bordetella , Animals , Bordetella , Cells, Cultured , Evaluation Studies as Topic , Muscle Contraction/drug effects , Muscle, Smooth, Vascular/drug effects
8.
Biochemistry ; 29(26): 6128-31, 1990 Jul 03.
Article in English | MEDLINE | ID: mdl-1698450

ABSTRACT

The binding of ATP to pertussis toxin and its components, the A subunit and B oligomer, was investigated. Whereas, radiolabeled ATP bound to the B oligomer and pertussis toxin, no binding to the A subunit was observed. The binding of [3H]ATP to pertussis toxin and the B oligomer was inhibited by nucleotides. The relative effectiveness of the nucleotides was shown to be ATP greater than ATP greater than GTP greater than CTP greater than TTP for pertussis toxin and ATP greater than GTP greater than TTP greater than CTP for the B oligomer. Phosphate ions inhibited the binding of [3H]ATP to pertussis toxin in a competitive manner; however, the presence of phosphate ions was essential for binding of ATP to the B oligomer. The toxin substrate, NAD, did not affect the binding of [3H]ATP to pertussis toxin, although the glycoprotein fetuin significantly decreased binding. These results suggest that the binding site for ATP is located on the B oligomer and is distinct from the enzymatically active site but may be located near the eukaryotic receptor binding site.


Subject(s)
Adenosine Triphosphate/metabolism , Pertussis Toxin , Virulence Factors, Bordetella/metabolism , Binding Sites , Binding, Competitive , NAD/metabolism , Nucleotides/metabolism , Peptide Fragments/metabolism , Phosphates/metabolism , Protein Binding , alpha-Fetoproteins/metabolism
9.
Infect Immun ; 58(5): 1456-60, 1990 May.
Article in English | MEDLINE | ID: mdl-2323823

ABSTRACT

Injection of sonic extracts of Bordetella parapertussis into the shaved backs of guinea pigs produced hemorrhagic necrosis, which previously has been attributed to the action of heat-labile toxin. As heat-labile toxin was purified from this crude mixture, its ability to induce hemorrhagic lesions decreased significantly. However, ischemic lesions were apparent after injection of the purified toxin. These lesions, while not hemorrhagic in nature, were marked by erythema surrounded by a region in which the ischemia was apparent. Exogenous agents were found to alter the nature of the skin lesion induced by heat-labile toxin. The lipid A portion of endotoxin in combination with heat-labile toxin caused hemorrhagic lesions surrounded by a ring of ischemia, whereas bovine serum albumin increased the area of erythema. While the nature of lesions induced by heat-labile toxin was affected by exogenous agents, the diameter of ischemia produced by the toxin was found to be independent of the presence of these agents and was linear with toxin dose. These results indicate that induction of hemorrhagic necrosis may not be a reliable indicator of heat-labile toxin activity. Instead, measurement of the ischemic lesion produced by heat-labile toxin may be a useful assay for the toxin.


Subject(s)
Bacterial Toxins/toxicity , Bordetella/pathogenicity , Ischemia/chemically induced , Skin/blood supply , Transglutaminases , Virulence Factors, Bordetella , Animals , Bacterial Toxins/isolation & purification , Endotoxins/pharmacology , Guinea Pigs , Lipid A/pharmacology , Necrosis/chemically induced , Time Factors
10.
J Immunol ; 144(9): 3529-34, 1990 May 01.
Article in English | MEDLINE | ID: mdl-1691761

ABSTRACT

To understand the immunologic characteristics of pertussis toxin molecule and to explore the possibility of developing a synthetic vaccine, T cell epitopes on the enzymatic S1 subunit of pertussis toxin were studied by measuring the proliferative response of immune murine lymph node cells and T cell lines to Ag and to synthetic peptides. The maximum in vitro T cell proliferative response was obtained by stimulating immune lymphoid cells with 20 nM of the enzymatic S1 subunit. When the T cell proliferative response of murine lymphoid cells with different MHC backgrounds was tested, only mice bearing the H-2d haplotype were high responder to the S1 subunit. To determine T cell epitopes on the S1 subunit, the proliferative response of BALB/c immune lymphoid cells to several synthetic S1 peptides was measured. Only the peptide containing amino acid residues, 65-79, was recognized by BALB/c lymphoid cells and was confirmed to contain a T cell epitope by generating S1 specific BALB/c T cell line. By using this T cell line, the response of BALB/c mice to the S1 subunit as well as to peptide 65-79 was shown to be restricted to the I-Ad sublocus of class II Ag. Finally, we showed that lymph node cells of mice immunized with peptide 65-79 respond to the native S1 subunit.


Subject(s)
Lymphocyte Activation , Pertussis Toxin , T-Lymphocytes/immunology , Virulence Factors, Bordetella/immunology , Amino Acid Sequence , Animals , Cells, Cultured , Dose-Response Relationship, Immunologic , Epitopes , In Vitro Techniques , Lymph Nodes/immunology , Mice , Mice, Inbred Strains , Molecular Sequence Data
11.
FEMS Microbiol Lett ; 55(3): 285-9, 1990 Feb.
Article in English | MEDLINE | ID: mdl-2323550

ABSTRACT

A purification scheme was devised for a 69-kDa outer membrane protein of Bordetella pertussis, a virulence-associated protein which may play a role in the pathogenesis of the organism. The protein was purified to apparent homogeneity by heating B. pertussis cells for 1 h at 60 degrees C followed by DEAE-Sepharose and Affi-Gel Blue chromatography. Antibodies found in sera obtained from patients diagnosed as having pertussis reacted with this protein. This purification scheme should be useful for the production of the 69 kDa protein which is currently being evaluated as a pertussis vaccine candidate.


Subject(s)
Antigens, Bacterial/isolation & purification , Bordetella pertussis/immunology , Virulence Factors, Bordetella/isolation & purification , Chromatography, Affinity , Chromatography, Gel , Molecular Weight , Pertussis Vaccine
12.
J Exp Med ; 171(1): 63-73, 1990 Jan 01.
Article in English | MEDLINE | ID: mdl-2295882

ABSTRACT

Immunization with the 69-kD outer membrane protein (OMP) of Bordetella pertussis protected neonatal mice against lethal respiratory challenge with B. pertussis 18323. Active immunization elicited a serum IgG anti-69-kD OMP response at the time of challenge, with IgG anti-69-kD OMP antibodies detected in bronchoalveolar lavage fluid after challenge. Intravenous administration of BPE8, a monoclonal IgG1 anti-69-kD OMP, also protected young mice against B. pertussis challenge. Intravenously injected BPE8 was detected in the lungs of mice at the time of aerosol challenge, suggesting that the presence of specific antibody in the lungs may mediate protection. Thus the 69-kD OMP of B. pertussis is a protective antigen in mice that elicits specific serum antibody that can transude to the lung. The 69-kD OMP was detected in a preparation of a Takeda acellular vaccine by immunoblot analysis and a serum antibody response to the 69-kD OMP was observed in 18-mo-old children boosted with this preparation of Japanese acellular vaccine. Our results demonstrate that the B. pertussis 69-kD OMP is a protective antigen in animals, is immunogenic in humans, and is present in a preparation of acellular pertussis vaccine that is widely used in Japan. These findings indicate that the 69-kD OMP should be seriously considered as a candidate for inclusion in new formulations of antigenically defined acellular pertussis vaccines.


Subject(s)
Bacterial Outer Membrane Proteins/metabolism , Bordetella pertussis/physiology , Whooping Cough/immunology , Animals , Antibodies, Monoclonal , Bacterial Outer Membrane Proteins/immunology , Bacterial Outer Membrane Proteins/isolation & purification , Bordetella pertussis/immunology , Bordetella pertussis/pathogenicity , Immunization , Immunization, Passive , Mice , Mice, Inbred BALB C , Molecular Weight
13.
Springfield, VA; U.S. National Technical Information Service; 1990. 408 p. graf. (PB91-110478).
Monography in English | PAHO | ID: pah-9043
14.
Infect Immun ; 57(11): 3324-30, 1989 Nov.
Article in English | MEDLINE | ID: mdl-2478471

ABSTRACT

The binding of pertussis toxin and its subunits to cell surface receptors and purified glycoproteins was examined. The interaction of pertussis toxin with components of two variant Chinese hamster ovary (CHO) cell lines was studied. These cell lines are deficient in either sialic acid residues (LEC 2) or sialic acid and galactose residues (LEC 8) on cell surface macromolecules. The binding of pertussis toxin to components of these cells differed from the binding of the toxin to wild-type components. Although the toxin bound to a 165,000-dalton glycoprotein found in N-octylglucoside extracts of wild-type cells, it did not bind to components found in extracts of LEC 2 cells. In contrast, the toxin bound to components found in extracts of LEC 8 cells, which are variant cells that contain increased amounts of terminal N-acetylglucosamine residues on cell surface macromolecules. These results suggest that the receptor for pertussis toxin on CHO cells contains terminal acetamido-containing sugars. The cytopathic effect of the toxin on both types of variant cells was much reduced compared with its effects on wild-type cells. Thus, optimal functional binding of pertussis toxin appears to require a complete sialyllactosamine (NeuAc----Gal beta 4GlcNAc) sequence on surface macromolecules. In addition to studying the nature of the eucaryotic receptor for pertussis toxin, we examined corresponding binding sites for glycoproteins on the toxin molecule. Binding of both S2-S4 and S3-S4 dimers of the toxin to cellular components and purified glycoproteins was observed. The two dimers bound to a number of glycoproteins containing N-linked oligosaccharides but not O-linked oligosaccharides, and differences in the binding of the two dimers to some glycoproteins was noted. These data indicate that the holotoxin molecule contains at least two glycoprotein-binding sites which may have slightly different specificities for glycoproteins.


Subject(s)
Glycoproteins/metabolism , Pertussis Toxin , Virulence Factors, Bordetella/metabolism , Adenosine Diphosphate Ribose/metabolism , Animals , Binding Sites , Carbohydrate Metabolism , Carbohydrate Sequence , Cell Line , Cricetinae , Erythrocyte Membrane/metabolism , Eukaryotic Cells/metabolism , Geese/blood , Molecular Sequence Data , Molecular Weight , alpha-Fetoproteins/metabolism
16.
Pediatr Infect Dis J ; 8(8): 502-7, 1989 Aug.
Article in English | MEDLINE | ID: mdl-2771530

ABSTRACT

We investigated the rates of local and systemic reactions following 9920 diphtheria-tetanus toxoids-pertussis immunizations from 25 lots of commercially available, United States-licensed diphtheria-tetanus toxoids-pertussis adsorbed vaccines from four manufacturers as a function of vaccine lot, endotoxin content, pertussis vaccine potency and percent of mouse weight gain. There were significant differences between the rates of reactions by lot for all local and systemic reactions except convulsions and hypotonic hyporesponsive episodes. For these latter reactions there were insufficient cases for analyses. P was less than 0.0001 for local reactions, fever, drowsiness, fretfulness, anorexia and screaming and 0.017 for vomiting. No single lot was associated with the highest or lowest rate of reactions for more than 3 of the 11 reactions. There was a significant positive association of endotoxin unit (EU) content and the percent of vaccine recipients who developed fever (P = 0.004). Fever increased in frequency from 20.6% of children immunized with vaccine lots that contained 2500 EU to 55.1% of children immunized with vaccine lots containing 40,000 EU. There were significant positive associations of all local reactions and pertussis vaccine potency (P = 0.0004), and percent of mouse weight gain (P less than 0.0001). There was also a positive association of percent mouse weight gain and persistent screaming (P = 0.001). However, for the majority of reactions there was no clinically meaningful associations between reaction rates and the biological properties of the vaccine studied.


Subject(s)
Diphtheria Toxoid/adverse effects , Endotoxins/adverse effects , Pertussis Vaccine/adverse effects , Tetanus Toxoid/adverse effects , Vaccination/adverse effects , Weight Gain , Animals , Child , Child, Preschool , Crying , Erythema/chemically induced , Fever/chemically induced , Humans , Infant , Mice , Sleep Stages
17.
Infect Immun ; 57(6): 1760-4, 1989 Jun.
Article in English | MEDLINE | ID: mdl-2722238

ABSTRACT

Immunization of mice with the dimeric subunits of pertussis toxin (S2-S4 and S3-S4) induced an antibody response detectable by enzyme-linked immunosorbent assay and immunoblot techniques. These antibodies were able to neutralize the ability of pertussis toxin to alter the morphology of Chinese hamster ovary cells. Mice immunized with the dimers were also protected against the leukocytosis-promoting effects of toxin. Based on these data, the dimers of pertussis toxin may be considered for further study as potential vaccine candidates.


Subject(s)
Antibodies, Bacterial/biosynthesis , Pertussis Toxin , Virulence Factors, Bordetella/immunology , Animals , Cell Line , Cricetinae , Female , Immune Sera/analysis , Mice , Neutralization Tests , Ovary , Protein Conformation , Virulence Factors, Bordetella/administration & dosage , Virulence Factors, Bordetella/isolation & purification
18.
Infect Immun ; 57(3): 944-50, 1989 Mar.
Article in English | MEDLINE | ID: mdl-2465274

ABSTRACT

To identify the neutralizing epitopes on the S1 subunit (A promoter) of pertussis toxin, we characterized anti-S1 monoclonal antibodies (MAbs) X2X5, 3CX4, and 6FX1. We confirmed by immunoblot analysis that these MAbs bind to the S1 subunit and not to the B oligomer of pertussis toxin and that they recognize different epitopes by a competitive binding enzyme-linked immunosorbent assay. These MAbs had differential abilities to neutralize the lymphocytosis-promoting factor activity of pertussis toxin in mice: 3CX4 and 6FX1 had partial neutralizing abilities, while MAb X2X5 had none. With these MAbs, the epitopes on the S1 subunit were examined by using trypsinized S1 peptides, recombinant truncated S1 molecules, and synthetic peptides. The non-neutralizing MAb X2X5 bound in immunoblots to tryptic peptides of various sizes as small as 1.5 kilodaltons; the neutralizing MAbs 3CX4 and 6FX1 bound only to a 24-kilodalton tryptic peptide band. Immunoblot studies with recombinant truncated S1 molecules demonstrated that amino acid residues 7 to 14 and 15 to 26 play an important role in the binding of neutralizing MAbs and the non-neutralizing MAb, respectively. The binding of these MAbs was not dependent upon the presence of C-terminal amino acid residues 188 to 234. To further define B-cell epitopes, the binding of the MAbs we tested to synthetic peptides representing the entire S1 subunit were examined. Neutralizing MAbs 3CX4 and 6FX1 bound to none of these peptides, further suggesting that these MAbs recognize conformational epitopes. The non-neutralizing MAb X2X5 bound to peptides 11 to 26 and 16 to 30, demonstrating that the major antigenic determinant recognized by this MAb is a linear epitope located within residues 16 to 26.


Subject(s)
Antibodies, Bacterial/immunology , Antibodies, Monoclonal/immunology , Pertussis Toxin , Virulence Factors, Bordetella/immunology , Antibody Specificity , B-Lymphocytes/immunology , Binding, Competitive , Blotting, Western , DNA Mutational Analysis , Epitopes , Molecular Weight , Oligopeptides/immunology , Peptide Fragments/immunology
19.
Hybridoma ; 8(1): 37-51, 1989 Feb.
Article in English | MEDLINE | ID: mdl-2466764

ABSTRACT

Six monoclonal antibodies (MAbs) to pertussis toxin (PT) have been generated and characterized. Five of these MAbs (3CX4, 3C4D, 6D11C, 6FX1, and X2X5) interact with determinants on the catalytic subunit (S1) of PT, and one (6DX3) is specific for subunit S4. The MAbs are divided into three groups based upon their ability to neutralize the effects of PT in a Chinese hamster ovary (CHO) cell assay. Three of the MAbs (3CX4, 3C4D and 6D11C) had high neutralization titers, one MAb (6FX1) displayed weak neutralizing activity, and two MAbs (X2X5 and 6DX3) had no neutralizing ability. The combination of one of the high titer MAbs (3CX4) with the low titer MAb (6FX1) resulted in a synergistic enhancement of neutralizing capability. F(ab')2 fragments prepared from MAb's 3CX4 and X2X5 displayed activities in the CHO-cell assay which were identical to the native MAb's. The ability of the MAbs to neutralize PT in the CHO-cell toxin neutralization assay correlated with their ability to inhibit the in vitro ADP-ribosylation of PT. A competition ELISA method demonstrated that this panel of MAbs recognizes at least four separate epitopes on the PT molecule. Biotin-conjugated MAbs were shown to be useful reagents to probe the interaction of pertussis toxin with fetuin.


Subject(s)
Antibodies, Monoclonal/immunology , Pertussis Toxin , Virulence Factors, Bordetella/immunology , Adenosine Diphosphate Ribose/metabolism , Animals , Antibody Specificity , Antigen-Antibody Reactions , Cricetinae , Epitopes , In Vitro Techniques , Neutralization Tests , Protein Binding , Structure-Activity Relationship , alpha-Fetoproteins/metabolism
20.
J Biol Chem ; 264(1): 564-8, 1989 Jan 05.
Article in English | MEDLINE | ID: mdl-2535846

ABSTRACT

The 2 cysteine residues present in the A subunit of pertussis toxin form a disulfide bond in the conformation of the toxin secreted from the bacteria. Previous studies have shown that reduction of this bond is necessary for activation of the enzyme. We have found that reduction of this bond also alters the conformation of the A subunit such that it no longer readily associates with the B oligomer of the toxin, a finding which may have implications concerning the form of the toxin found within the eukaryotic cell. In addition, we have demonstrated that reduction of the disulfide bond of the purified A subunit followed by treatment with sulfhydryl-modifying reagents such as N-ethylmaleimide or 5,5'-dithiobis-(2-nitrobenzoic acid) results in inhibition of the NAD glycohydrolase activity of the protein. When a tryptic fragment of the A subunit which contains only 1 of the cysteine residues (Cys-41) of the native protein was reacted with N-ethylmaleimide, the NAD glycohydrolase activity of this fragment was substantially reduced. These data indicate that Cys-41 may be in a region of the molecule which is critical for the enzymatic activity of the toxin.


Subject(s)
Cysteine , Pertussis Toxin , Virulence Factors, Bordetella , Animals , Cell Line , Cell Membrane/metabolism , Disulfides/metabolism , Ethylmaleimide/pharmacology , Macromolecular Substances , Membrane Proteins/metabolism , Molecular Weight , NAD+ Nucleosidase/metabolism , Protein Conformation , Virulence Factors, Bordetella/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...